102 related articles for article (PubMed ID: 8664272)
1. Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells.
Barnes KM; Dickstein B; Cutler GB; Fojo T; Bates SE
Biochemistry; 1996 Apr; 35(15):4820-7. PubMed ID: 8664272
[TBL] [Abstract][Full Text] [Related]
2. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
Scala S; Dickstein B; Regis J; Szallasi Z; Blumberg PM; Bates SE
Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959
[TBL] [Abstract][Full Text] [Related]
3. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of P-glycoprotein transport by protein kinase inhibition.
Bates SE; Lee JS; Dickstein B; Spolyar M; Fojo AT
Biochemistry; 1993 Sep; 32(35):9156-64. PubMed ID: 7690250
[TBL] [Abstract][Full Text] [Related]
5. A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein.
Lin JT; Sharma R; Grady JJ; Awasthi S
Drug Metab Dispos; 2001 Feb; 29(2):103-10. PubMed ID: 11159798
[TBL] [Abstract][Full Text] [Related]
6. Selective modulation of P-glycoprotein-mediated drug resistance.
Bebawy M; Morris MB; Roufogalis BD
Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
[TBL] [Abstract][Full Text] [Related]
7. Mode of action of torilin in multidrug-resistant cancer cell lines.
Kim SE; Hong YS; Kim YC; Lee JJ
Planta Med; 1998 May; 64(4):335-8. PubMed ID: 9619116
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogens and steroid hormones: substrates of the human P-glycoprotein.
Rao US; Fine RL; Scarborough GA
Biochem Pharmacol; 1994 Jul; 48(2):287-92. PubMed ID: 7914405
[TBL] [Abstract][Full Text] [Related]
9. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
Fong WF; Wan CK; Zhu GY; Chattopadhyay A; Dey S; Zhao Z; Shen XL
Planta Med; 2007 Mar; 73(3):212-20. PubMed ID: 17318783
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of P-glycoprotein function and expression by kaempferol and quercetin.
Limtrakul P; Khantamat O; Pintha K
J Chemother; 2005 Feb; 17(1):86-95. PubMed ID: 15828450
[TBL] [Abstract][Full Text] [Related]
11. In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein.
Wang EJ; Casciano CN; Clement RP; Johnson WW
Drug Metab Dispos; 2000 May; 28(5):522-8. PubMed ID: 10772630
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein.
Kang CD; Ahn BK; Jeong CS; Kim KW; Lee HJ; Yoo SD; Chung BS; Kim SH
Exp Cell Res; 2000 Apr; 256(1):300-7. PubMed ID: 10739677
[TBL] [Abstract][Full Text] [Related]
13. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
Barthomeuf C; Demeule M; Grassi J; Saidkhodjaev A; Beliveau R
Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
Elamanchili P; McEachern C; Burt H
J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
16. Progesterone photoaffinity labels P-glycoprotein in multidrug-resistant human leukemic lymphoblasts.
Qian XD; Beck WT
J Biol Chem; 1990 Nov; 265(31):18753-6. PubMed ID: 1977745
[TBL] [Abstract][Full Text] [Related]
17. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
Liu Z; Lheureux F; Pouliot JF; Heckel A; Bamberger U; Georges E
Mol Pharmacol; 1996 Sep; 50(3):482-92. PubMed ID: 8794885
[TBL] [Abstract][Full Text] [Related]
18. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
19. Pgp efflux pump decreases the cytostatic effect of CENP-E inhibitor GSK923295.
Tcherniuk SO; Oleinikov AV
Cancer Lett; 2015 May; 361(1):97-103. PubMed ID: 25725449
[TBL] [Abstract][Full Text] [Related]
20. The effect of fatty acids and analogues upon intracellular levels of doxorubicin in cells displaying P-glycoprotein mediated multidrug resistance.
Abulrob AN; Mason M; Bryce R; Gumbleton M
J Drug Target; 2000; 8(4):247-56. PubMed ID: 11144235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
